AAP
PPBT

Arax Advisory Partners’s Purple Biotech PPBT Stock Holding History

Arax Advisory Partners’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44K Buy
+1,453
New +$4.9K ﹤0.01% 4777

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
IA
IFG Advisory Atlanta, Georgia $2.85B AUM 26.07% 1-Year Est. Return

Arax Advisory Partners's PPBT Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Purple Biotech (PPBT) in Q2 2026: 1,453 shares worth $2.44K. The stake represents ﹤0.01% of the portfolio and ranks #4777 among its holdings.

13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Arax Advisory Partners held 1,453 shares of Purple Biotech worth $2.44K as of Q2 2026.
  • Purple Biotech was a new Arax Advisory Partners position in Q2 2026.
  • Purple Biotech made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4777 holding.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.